Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1971 1
1973 1
1975 3
1978 2
1979 2
1981 3
1982 3
1983 3
1984 2
1985 3
1986 4
1987 1
1989 1
1990 4
1991 5
1992 1
1993 5
1994 2
1995 4
1996 7
1997 1
1999 1
2000 6
2001 5
2002 4
2003 3
2004 2
2005 3
2006 4
2007 4
2008 2
2009 3
2010 3
2011 3
2012 4
2014 3
2015 4
2016 1
2017 5
2018 5
2019 11
2020 10
2021 6
2022 6
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "In Utero Drug Withdrawal"
Page 1
Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS).
Mangat AK, Schmölzer GM, Kraft WK. Mangat AK, et al. Semin Fetal Neonatal Med. 2019 Apr;24(2):133-141. doi: 10.1016/j.siny.2019.01.009. Epub 2019 Feb 5. Semin Fetal Neonatal Med. 2019. PMID: 30745219 Free PMC article. Review.
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants develop after intrauterine maternal drug exposure. All infants with documented in utero opioid exposure, or a high pre-test probability of exposure should have monitoring …
Neonatal abstinence syndrome is defined by signs and symptoms of withdrawal that infants develop after intrauterine maternal drug …
Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment.
Wachman EM, Schiff DM, Silverstein M. Wachman EM, et al. JAMA. 2018 Apr 3;319(13):1362-1374. doi: 10.1001/jama.2018.2640. JAMA. 2018. PMID: 29614184 Review.
IMPORTANCE: Neonatal abstinence syndrome, which occurs as a result of in utero opioid exposure, affects between 6.0 and 20 newborns per 1000 live US births. ...Thirteen studies were identified that evaluated established or novel neonatal abstinence syndrome assessment meth …
IMPORTANCE: Neonatal abstinence syndrome, which occurs as a result of in utero opioid exposure, affects between 6.0 and 20 newborns p …
Duration and Timing of In Utero Opioid Exposure and Incidence of Neonatal Withdrawal Syndrome.
Wang Y, Berger L, Durrance C, Kirby RS, Kuo D, Pac J, Ehrenthal DB. Wang Y, et al. Obstet Gynecol. 2023 Sep 1;142(3):603-611. doi: 10.1097/AOG.0000000000005289. Obstet Gynecol. 2023. PMID: 37548391
OBJECTIVE: To evaluate the association between prenatal prescription opioid analgesic exposure (duration, timing) and neonatal opioid withdrawal syndrome (NOWS). METHODS: We conducted a retrospective cohort study of Wisconsin Medicaid-covered singleton live births from 201 …
OBJECTIVE: To evaluate the association between prenatal prescription opioid analgesic exposure (duration, timing) and neonatal opioid wit …
The role and use of progestogens.
Whitehead MI, Hillard TC, Crook D. Whitehead MI, et al. Obstet Gynecol. 1990 Apr;75(4 Suppl):59S-76S; discussion 81S-83S. Obstet Gynecol. 1990. PMID: 2179792 Review.
The addition of a cyclic progestogen reduces this risk, but it is not clear whether the reduction is to, or below, that observed in an untreated population. Protective doses of C-19 (norethindrone) and C-21 (medroxy-progesterone acetate) progestogens are suggested. ...In a …
The addition of a cyclic progestogen reduces this risk, but it is not clear whether the reduction is to, or below, that observed in a …
Prenatal effects of alcohol.
Abel EL. Abel EL. Drug Alcohol Depend. 1984 Sep;14(1):1-10. doi: 10.1016/0376-8716(84)90012-7. Drug Alcohol Depend. 1984. PMID: 6386408 Review.
Central nervous system dysfunction includes mental retardation, the most serious consequence of in utero alcohol exposure, hyperactivity, sleep disorders and miscellaneous behavioral difficulties. ...However, without evidence of maternal drinking during pregnancy, this dia …
Central nervous system dysfunction includes mental retardation, the most serious consequence of in utero alcohol exposure, hyperactiv …
Opioid neonatal abstinence syndrome: controversies and implications for practice.
Wolff K, Perez-Montejano R. Wolff K, et al. Curr Drug Abuse Rev. 2014;7(1):44-58. doi: 10.2174/1874473707666141015215141. Curr Drug Abuse Rev. 2014. PMID: 25323126 Review.
The following review will address current and historical controversies surrounding these issues and will examine the evidence concerned with the evaluation of neonates exposed to methadone in utero. The key findings are as follows: A variety of NAS scales are used to asses …
The following review will address current and historical controversies surrounding these issues and will examine the evidence concerned with …
Impact of in utero opioid exposure on newborn outcomes: beyond neonatal opioid withdrawal syndrome.
Bailey BA, Shah DS, Boynewicz KL, Justice NA, Wood DL. Bailey BA, et al. J Matern Fetal Neonatal Med. 2022 Dec;35(25):9383-9390. doi: 10.1080/14767058.2022.2035713. Epub 2022 Feb 2. J Matern Fetal Neonatal Med. 2022. PMID: 35109759
BACKGROUND AND OBJECTIVES: Research on in utero opioid exposure impacts has focused on Neonatal Opioid Withdrawal Syndrome (NOWS). ...RESULTS: Compared to biochemically verified controls, exposed newborns had higher rates of fetal growth restriction, weighed less, h …
BACKGROUND AND OBJECTIVES: Research on in utero opioid exposure impacts has focused on Neonatal Opioid Withdrawal Syndrome (NO …
Neonatal Abstinence Syndrome: Update on Diagnostic and Therapeutic Strategies.
Raffaeli G, Cavallaro G, Allegaert K, Wildschut ED, Fumagalli M, Agosti M, Tibboel D, Mosca F. Raffaeli G, et al. Pharmacotherapy. 2017 Jul;37(7):814-823. doi: 10.1002/phar.1954. Epub 2017 Jul 2. Pharmacotherapy. 2017. PMID: 28519244 Review.
Both prescription opioid use and illicit opioid abuse have increased dramatically in recent years. Prolonged in utero drug exposure may result in neonatal abstinence syndrome (NAS), an acute multisystemic clinical entity that occurs in the first days of life. ...The …
Both prescription opioid use and illicit opioid abuse have increased dramatically in recent years. Prolonged in utero drug exp …
Serotonin reuptake inhibitor-induced perinatal complications.
Gentile S. Gentile S. Paediatr Drugs. 2007;9(2):97-106. doi: 10.2165/00148581-200709020-00003. Paediatr Drugs. 2007. PMID: 17407365 Review.
A computerized search of MEDLINE (1966-January 2007) and PsycINFO (1974-January 2007) databases was performed. Articles describing perinatal complications after late in utero exposure to SRIs were selected and also reviewed for additional references. ...Such symptoms are n …
A computerized search of MEDLINE (1966-January 2007) and PsycINFO (1974-January 2007) databases was performed. Articles describing perinatal …
Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
McPhail BT, Emoto C, Butler D, Fukuda T, Akinbi H, Vinks AA. McPhail BT, et al. J Clin Pharmacol. 2021 Jul;61(7):857-870. doi: 10.1002/jcph.1811. Epub 2021 Feb 1. J Clin Pharmacol. 2021. PMID: 33382111 Review.
Chronic intrauterine exposure to psychoactive drugs often results in neonatal opioid withdrawal syndrome (NOWS). When nonpharmacologic measures are insufficient in controlling NOWS, morphine, methadone, and buprenorphine are first-line medications commonly used to treat in …
Chronic intrauterine exposure to psychoactive drugs often results in neonatal opioid withdrawal syndrome (NOWS). When nonpharmacologi …
152 results